Others
- Page Path
-
- HOME
- ARTICLE CATEGORY
- Others
- Correspondence
- Correspondence to editorial on “UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL”
- Renyu Zhang, Ding Wei, Zhinan Chen, Huijie Bian
- Clin Mol Hepatol. 2025;31(1):e58-e60. Published online July 29, 2024
-
View: 546 Download: 43
- Reply to Correspondence
- Reply to correspondence on “UBE2S: A novel driver of HIF-1alpha-induced metabolic reprogramming in hepatocellular carcinoma”
- Martina Mang Leng Lei, Terence Kin Wah Lee
- Clin Mol Hepatol. 2025;31(1):e119-e120. Published online August 5, 2024
-
View: 451 Download: 22
- Correspondence
- Correspondence to letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”
- Gi-Ae Kim, Seung Won Choi, Young-Suk Lim
- Clin Mol Hepatol. 2025;31(1):e108-e109. Published online August 5, 2024
-
View: 451 Download: 24
- Steatotic liver disease in chronic hepatitis C related hepatocellular carcinoma: Inflictor or bystander?: Correspondence to editorial on “Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan”
- Chung-Feng Huang, Ming-Lun Yeh, Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, Ming-Lung Yu
- Clin Mol Hepatol. 2025;31(1):e64-e66. Published online August 19, 2024
-
View: 495 Download: 31
- PNPLA3 is one of the bridges between TM6SF2 E167K variant and MASLD: Correspondence to editorial on “TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD”
- Baokai Sun, Likun Zhuang
- Clin Mol Hepatol. 2025;31(1):e67-e69. Published online September 10, 2024
-
View: 509 Download: 64
- Correspondence to editorial on “KCTD17-mediated Ras stabilization promotes hepatocellular carcinoma progression”
- Sang Bae Lee, KyeongJin Kim
- Clin Mol Hepatol. 2025;31(1):e78-e80. Published online September 10, 2024
-
View: 524 Download: 53
- Correspondence to editorial on “DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease”
- Amal Magdy, Hee-Jin Kim, Won Kim, Mirang Kim
- Clin Mol Hepatol. 2025;31(1):e70-e73. Published online September 10, 2024
-
View: 469 Download: 36
- Correspondence to editorial on “Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis”
- Hee Yeon Kim, Miyoung Choi, Dae Won Jun
- Clin Mol Hepatol. 2025;31(1):e48-e51. Published online September 11, 2024
-
View: 407 Download: 19
- Correspondence to letter to the editor on “Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis”
- Yuri Cho, Dae Won Jun
- Clin Mol Hepatol. 2025;31(1):e103-e104. Published online September 24, 2024
-
View: 407 Download: 21
- Correspondence to editorial on “Optimal cutoffs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis”
- Jung Hwan Yu, Seung Up Kim
- Clin Mol Hepatol. 2025;31(1):e52-e54. Published online September 24, 2024
-
View: 476 Download: 22
- Correspondence to letter to the editor on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”
- Sung Hwan Lee, Sun Young Yim, Ji Hoon Kim, Sunyoung S Lee, Ahmed O Kaseb, Peng Wei, Ju-Seog Lee
- Clin Mol Hepatol. 2025;31(1):e110-e112. Published online October 2, 2024
-
View: 492 Download: 31
- Correspondence to editorial on “Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis”
- Young-Joo Jin, Seung Up Kim
- Clin Mol Hepatol. 2025;31(1):e55-e57. Published online October 7, 2024
-
View: 396 Download: 12
- Correspondence to editorial 1 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 Trial”
- Sung Hwan Lee, Sun Young Yim, Ji Hoon Kim, Sunyoung S. Lee, Ahmed O. Kaseb, Ju-Seog Lee
- Clin Mol Hepatol. 2025;31(1):e81-e83. Published online October 7, 2024
-
View: 472 Download: 21
- Correspondence to editorial 2 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 trial”
- Sun Young Yim, Sung Hwan Lee, Ji Hoon Kim, Sunyoung S Lee, Ahmed O Kaseb, Ju-Seog Lee
- Clin Mol Hepatol. 2025;31(1):e84-e86. Published online October 7, 2024
-
View: 423 Download: 13
- Reply to Correspondence
- Reply to correspondence on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”
- Antonio Bertoletti, Anthony T Tan
- Clin Mol Hepatol. 2025;31(1):e113-e116. Published online October 11, 2024
-
View: 536 Download: 22
- Reply to correspondence on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”
- Hiroaki Kanzaki, Yujin Hoshida
- Clin Mol Hepatol. 2025;31(1):e121-e122. Published online October 11, 2024
-
View: 454 Download: 20
- Correspondence
- Correspondence to editorial on: “Gut microbiome and metabolome signatures in liver cirrhosis-related complications”
- Satya Priya Sharma, Ki Tae Suk
- Clin Mol Hepatol. 2025;31(1):e74-e77. Published online October 15, 2024
-
View: 642 Download: 36
- Correspondence to editorial on “Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis”
- Young Eun Chon, Jung Hwan Yu, Seung Up Kim
- Clin Mol Hepatol. 2025;31(1):e61-e63. Published online October 15, 2024
-
View: 396 Download: 16
- Correspondence to editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”
- Shunda Du, Karin Wisskirchen, Ke Zhang, Ulrike Protzer
- Clin Mol Hepatol. 2025;31(1):e44-e47. Published online October 21, 2024
-
View: 567 Download: 33
- Correspondence to letter to the editor on “Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study”
- Young Eun Chon, Dong Yun Kim, Hong Jae Chon, Do Young Kim
- Clin Mol Hepatol. 2025;31(1):e98-e100. Published online October 21, 2024
-
View: 424 Download: 28
- Correspondence to editorial on “Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: a multinational population-based cohort study from South Korea, Japan, and the UK”
- Kwanjoo Lee, Jaeyu Park, Jinseok Lee, Hayeon Lee, Yeonjung Ha, Dong Keon Yon
- Clin Mol Hepatol. 2025;31(1):e87-e89. Published online October 29, 2024
-
View: 335 Download: 9
- Correspondence to letter to the editor on “Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis”
- Hee Yeon Kim, Miyoung Choi, Dae Won Jun
- Clin Mol Hepatol. 2025;31(1):e105-e107. Published online November 4, 2024
-
View: 295 Download: 15
- Correspondence to letter to the editor on “Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis”
- Moon Haeng Hur, Yoon Jun Kim
- Clin Mol Hepatol. 2025;31(1):e93-e95. Published online November 6, 2024
-
View: 404 Download: 24
- Correspondence to letter to the editor 2 on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”
- Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su
- Clin Mol Hepatol. 2025;31(1):e101-e102. Published online November 6, 2024
-
View: 299 Download: 9
- Reply to Correspondence
- Reply to correspondence on “Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: A multinational population-based cohort study from South Korea, Japan, and the UK”
- Yang-Hyun Baek
- Clin Mol Hepatol. 2025;31(1):e123-e124. Published online November 6, 2024
-
View: 266 Download: 7
- Reply to correspondence on “Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis”
- Mirko Zoncapè, Emmanuel A. Tsochatzis
- Clin Mol Hepatol. 2025;31(1):e117-e118. Published online November 11, 2024
-
View: 290 Download: 11
- Correspondence
- Correspondence to editorial on “Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma”
- Yu-Hang Ye, Shao-Lai Zhou
- Clin Mol Hepatol. 2025;31(1):e90-e92. Published online November 11, 2024
-
View: 344 Download: 11
- Correspondence to letter to the editor 1 on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”
- Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su
- Clin Mol Hepatol. 2025;31(1):e96-e97. Published online November 11, 2024
-
View: 295 Download: 7
- Erratum
- Erratum to ‘Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction’ [Clin Mol Hepatol 2024;30:539-560]
- Mehrangiz Dezhbord, Seong Ho Kim, Soree Park, Da Rae Lee, Nayeon Kim, Juhee Won, Ah Ram Lee, Dong-Sik Kim, Kyun-Hwan Kim
- Clin Mol Hepatol. 2024;30(4):1060-1065. Published online July 24, 2024
-
View: 1066 Download: 28 Web of Science: 1 Crossref: 1
- Reply to Correspondence
- Reply to correspondence on “Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction”
- Cho-Rong Lee, Sung-Gyoo Park
- Clin Mol Hepatol. 2024;30(4):1053-1054. Published online July 17, 2024
-
View: 1346 Download: 43 Web of Science: 1 Crossref: 1
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
Video abstract
-
- Examining the therapeutic landscape of beta-blockers in portal hypertension
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor14.0First decision
07 Days
Publication after acceptance
03 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2023-2025)
|
|||||||
